Returns Breakdown
| Return on Assets | (0.81) | |
| Return on Equity | (10.51) | |
| Return Capital | (0.97) | |
| Return on Sales | (36.86) |
Is Cel Sci (NYSEMKT:CVM) outlook positive for January 2021?
 | By Vlad Skutelnik | Macroaxis Story |
Cel Sci Price to Book Value is relatively stable at the moment as compared to the past year. The company's current Price to Book Value is estimated at 71.54. Price to Sales Ratio is expected to hike to 505.12 this year, although the value of Earnings Before Interest Taxes and Depreciation Amortization EBITDA will most likely fall to (19.1 M). In this article, we will summarize Cel Sci as a potential position in addition to your existing holdings. We will summarize why it could be a game-changer for Cel Sci stakeholders.
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Rifka Kats
On a scale of 0 to 100, Cel Sci holds a performance score of 3. The firm shows a Beta (market volatility) of -0.8606, which signifies possible diversification benefits within a given portfolio. Let's try to break down what Cel Sci's beta means in this case. As the market becomes more bullish, returns on owning Cel Sci are expected to decrease slowly. On the other hand, during market turmoil, Cel Sci is expected to outperform it slightly. Although it is vital to follow Cel Sci historical returns, it is good to be conservative about what you can do with the information regarding equity current trending patterns. The philosophy towards foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By analyzing Cel Sci technical indicators, you can presently evaluate if the expected return of 0.27% will be sustainable into the future. Please makes use of Cel Sci downside deviation, jensen alpha, as well as the relationship between the Jensen Alpha and downside variance to make a quick decision on whether Cel Sci price patterns will revert.
There are currently many different techniques concerning forecasting the market as a whole as well as predicting future values of individual securities such as CEL SCI Corp. Regardless of method or technology, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Predictive Modules for CEL SCI
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of CEL SCI's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Watch out for price decline
Please consider monitoring CEL SCI on a daily basis if you are holding a position in it. CEL SCI is trading at a penny-stock level, and the possibility of delisting is much higher compared to other stocks. However, just because the stock is trading under one dollar, does not mean it will be marked for deletion. Most exchanges require public instruments, such as CEL SCI stock to be traded above the $1 level to remain listed. If CEL SCI stock price falls below $1 for 30 consecutive trading days, the exchange can delist it. Once the company reaches this point, they will be sent an initial price violation notice directly from an exchange.
How important is CEL SCI's Liquidity
CEL SCI financial leverage refers to using borrowed capital as a funding source to finance CEL SCI Corp ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. CEL SCI financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to CEL SCI's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of CEL SCI's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between CEL SCI's total debt and its cash.
CEL SCI Gross Profit
CEL SCI Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing CEL SCI previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show CEL SCI Gross Profit growth over the last 10 years. Please check CEL SCI's gross profit and other fundamental indicators for more details.
Another angle On CEL SCI
Cel Sci shows above-average downside volatility for the selected time horizon. We advise investors to inspect Cel Sci further and ensure that all market timing and asset allocation strategies are consistent with the estimation of Cel Sci future alpha.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of CEL SCI Corp. Please refer to our Terms of Use for any information regarding our disclosure principles.